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Background:
 
The evolution of pain in relation to damage in the synovium, bone and cartilage in 
osteoarthritis (OA), coupled with their relation to wet biochemical markers are not well 
understood.
Objectives:
In this study we evaluated the relation between structural damage by MRI, clinical and pain 
sensitisation measures and wet biochemical biomarkers in knee OA.
Methods:
We recruited 130 participants fulfilling ACR criteria with advanced OA requiring total knee 
replacement (TKR) (n=80), mild OA having standard care (n=42) and non-OA controls (n=8). 
Knee MRI in 90 subjects (72 F, 18 M) was acquired and assessed by two radiologists with 
the MRI Knee Osteoarthritis Score (MOAKS). Overall MOAKS scores were created for Bone 
Marrow Lesions (BML), Cartilage Degradation (CD) and effusion/Hoffa synovitis (tSyn). Type 
II collagen cleavage products (CTX-II) were determined by ELISA. Clinical scoring was 
performed using the Western Ontario and McMaster Universities Osteoarthritis Index 
(WOMAC) for pain levels (WOMAC_P), Hospital Anxiety and Depression Scale (HADS),  
Body mass index (BMI) and pain sensitisation with pain pressure thresholds (PPT) of the 
patella by Quantitative Sensory Testing (QST). 
Results:
The mild OA group had a mean age of 63 +/-9 yr and the advanced OA group 69 +/- 9 yr.  
The advanced OA group had higher levels of pain, with a mean WOMAC_P of 58 +/- 22 
compared with the mild OA group who had a mean WOMAC_P of 40 +/-22. WOMAC_P 
correlated with the total number of regions with cartilage damage (nCD) (R=0.225, p=0.033) 
and total number of BMLs (nBML) (R=0.195, p=0.065) using BMI, age and HADS as 
covariates. Levels of CTX-II correlated with tSyn (R=0.313, p=0.03), nBML (R=0.252, 
p=0.019), number of osteophytes (R=0.33, p=0.002) and nCD (R=0.218, p=0.042), using 
BMI and age as covariates. The correlation for urinary CTX-II with tSyn (p=0.006) is shown in 
Figure 1 using a partial linear regression analysis of MOAKS, BMI and age. We also found 
CTX-II correlated with lesion load scores (total number of lesions multiplied by MOAKS size 
by % damage scores) for CD (R=0.277, p=0.009) and BML (r=0.308, p=0.004). PPT 
correlated with patella MOAKS scores for nBML (R=-0.221, p=0.038) and nCD (R=-0.279, 
p=0.009), with HADS, BMI and age as covariates.
Conclusion:
There is a direct correlation between the degree of cartilage damage and BMLs with pain in 
OA. Type II collagen degradation products were higher when there was more severe MRI-
detected synovitis, BMLs and cartilage damage in the knee joint, suggesting that the source 
of enzymes degrading type II collagen in OA, including matrix metalloproteinases, are also 
likely to be produced by synovium and bone (1) and not just cartilage, as previously 
hypothesised in other studies. There was also a correlation between pain sensitisation and 
frequency of BMLs and cartilage degradation, suggesting that molecular mediators of pain 
sensitisation, which we have shown are produced by BMLs (1), are a cause of patient-
reported OA pain.
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